Eli Lilly and Company (NYSE:LLY) Shares Down 0.3% After Analyst Downgrade
Eli Lilly and Company (NYSE:LLY – Get Free Report) shares traded down 0.3% on Monday after UBS Group lowered their price target on the stock from $1,100.00 to $1,050.00. UBS Group currently has a buy rating on the stock. Eli Lilly and Company traded as low as $812.03 and last traded at $821.39. 747,819 shares […]
